Intrathecal rituximab for the treatment of Epstein–Barr virus-associated encephalitis
Epstein–Barr virus (EBV)-associated encephalitis is seen in patients who have undergone allogeneic hematopoietic stem cell transplant and can be associated with significant morbidity and mortality. The mainstay of treatment has been antiviral therapy w…